Skip to main content
Optimi Health Corp. logo

Optimi Health Corp. — Investor Relations & Filings

Ticker · OPTI ISIN · CA68405H1001 LEI · 98450063FDFF8UD3Q652 CSE Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2024-05-31 Regulatory Filings
Country CA Canada
Listing CSE OPTI

About Optimi Health Corp.

https://www.optimihealth.ca/

Optimi Health Corp. is a GMP-certified pharmaceutical drug manufacturer and end-to-end drug researcher licensed to produce and supply controlled psychedelic substances. The company specializes in the production of MDMA and psilocybin, primarily supporting psychedelic-based mental health treatments. Additionally, Optimi operates a vertically integrated functional mushroom brand, developing scalable, natural mushroom formulations aimed at the health and wellness sector. This structure allows the company to serve both regulated pharmaceutical supply chains and consumer wellness markets.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Regulatory Filings
2024-05-31 English
Interim MD&A - English.pdf
Regulatory Filings
2024-05-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-05-31 English
News release - English.pdf
Regulatory Filings
2024-05-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a Letter of Intent (LOI) between Optimi Health Corp. and ATMA Journey Centers to advance clinical trials for psilocybin-assisted therapy. It discusses the collaboration, clinical trial phases, and strategic partnership but does not contain any financial statements, regulatory filings, or detailed financial data. It is not an annual report, earnings release, or any form of financial report. It is also not a regulatory filing or certification. The content is primarily a corporate announcement about a business collaboration and clinical trial advancement, which fits best under the category of a general regulatory announcement or miscellaneous corporate news. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2024-05-22 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event related to a private placement financing by Optimi Health Corp. It includes specifics about the issuance of units, warrants, and related party transactions. The content focuses on a financing event and capital raising activity, not on full financial statements or annual/quarterly results. The document length is 6395 characters, which is sufficient for a detailed announcement but does not contain comprehensive financial statements or management discussion typical of an Interim/Quarterly Report or Annual Report. The nature of the document aligns with updates on company fundraising and capital structure changes. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP).
2024-05-17 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.